相关实验视频
Updated: Jul 18, 2026

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
37.5K
肠道微生物组和动脉样硬化相关脂质的因果关系:双向的门德尔随机化研究
Da Teng1,2, Wenjuan Jia1,2, Wenlong Wang1,2
1Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong, People's Republic of China.
BMC cardiovascular disorders
|March 2, 2024
概括
这项研究使用门德尔随机化来探索肠道细菌和血液脂质之间的因果关系. 某些肠道微生物与失脂症有关,为临床干预提供了潜在的目标.
科学领域:
- 微生物组研究的研究.
- 人类遗传学 人类遗传学
- 代谢性疾病是一种代谢性疾病.
背景情况:
- 观察性研究表明,肠道微生物群和血液脂质之间存在联系.
- 仅仅通过观察数据无法确定因果关系.
研究的目的:
- 通过双向双样本的门德尔随机化分析,研究肠道菌群和血液脂质之间的潜在因果关系.
主要方法:
- 利用了211个肠道菌群和5个血液脂质特征的全基因组关联研究 (GWAS) 总结统计数据.
- 应用了五种门德尔随机化 (MR) 方法,以逆变量加权回归 (IVW) 为主要方法.
- 进行敏感性分析以确保因果估计的可靠性.
主要成果:
- 确定了19种肠道菌群和脂质不良症之间的潜在因果关系.
- 特定的属和种类与增加或减少脱脂症风险有关.
- 家庭Desulfovibrionaceae在多次测试校正后显示出与阿波蛋白B (ApoB) 水平的显著负相关性.
结论:
- 这项研究支持特定肠道菌群和失脂症之间存在因果关系.
- 这些发现为开发针对肠道微生物群的临床干预方案提供了宝贵的参考.
相关概念视频
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

